Publication | Closed Access
Elevated serum c-erbB-2 antigen levels and decreased response to hormone therapy of breast cancer.
300
Citations
35
References
1995
Year
Patients with ER+/c-erbB-2+ metastatic breast cancer are less likely to respond to hormone treatment than ER+/c-erbB-2- patients. Their survival duration is also shorter.
| Year | Citations | |
|---|---|---|
Page 1
Page 1